抗生素耐药性不仅是生物学问题

本文是supported byChemonics International。

[伦敦]行为改变可能是防止耐药超级细菌增长的关键，这是一组医疗保健researchersand practitioners heard.

抗生素耐药性 - 细菌发展能够抵抗旨在杀死它们的药物的能力 - 到2050年，每年可能会导致超过1000万人死亡，根据世界卫生组织。

大多数对抗菌药物耐药性的研究都集中在医学科学上，但是社会和行为研究可以证明是鼓励抗菌药物生产者，处方者和用户提高对这些重要资源的态度的最佳方法。

“如果我们想减少这种抗生素的用途……我们必须解决一些基本原因，即我们的社会已经依靠它们。”

Clare Chandler, co-director of the Antimicrobial Resistance Centre at the London School of Hygiene and Tropical Medicine

“This is inherently a social problem as well as a biological problem, we cannot treat it only as something that is happening in the realm of biology, otherwise we can’t address it,” Clare Chandler, a medical anthropologist and the co-director of the Antimicrobial Resistance Centre at the London School of Hygiene and Tropical Medicine, told the panel at the UK’s Wellcome Collection on 5 February.

Chandler argues that global structural problems, which push people to return to work as quickly as possible when they are ill, mean that antibiotics are being used as a ‘quick fix’.

钱德勒说，对制药行业的监管不佳意味着其代表可以通过提供销售的经济激励措施来具有很大的影响力，从而导致抗生素的过度处方。

“在更大的范围内,我们使用抗生素to fix inequality,” she says. “If we want to reduce that antibiotic use … we have to fix some of these underlying reasons that our societies have become reliant on them.”

Multi-drug resistant strains of some microbes, such as结核，正在上升，滥用抗菌药物是这种耐药性的驱动力。

经济学家情报部门的健康研究分析师经理艾丽西亚·怀特（Alicia White）告诉小组，耐药性结核病对全球卫生安全构成了重大威胁，同时它也威胁到经济增长。

怀特说：“在非常人类的水平上，结核病会带来……成本可能会对家庭产生灾难性影响。”

全球旅行和滥用抗菌药物的危险有可能使这种国际超级细菌成为新的规范。

“行为和社会规范变化是一个非常复杂的发展领域，很难正确地衡量，” Chemonics International的英国全球卫生总监Andrew Tuttle说，该国际经济学情报部门组织了会议。

“When we think of global health security, there is an incredible sense of urgency around tackling the antimicrobial resistance issue and we know that effective behaviour change will be key to achieving that.”

本文是supported byChemonics International。